Company page
Cellromax Science Co., Ltd.
Cellromax Science Co., Ltd. is a public company traded under the ticker 471820 on the Korean market. The company has a market capitalization of approximately 34.3 million USD. Cellromax focuses on developing innovative solutions in its industry, contributing to advancements in technology and science.

- Ticker
- 471820
- Market cap
- $34.3M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other